Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/4/14 → 3/4/17 |
Funding
- PRA Health Sciences (GS-US-337-1118)
- Gilead Sciences, Inc. (GS-US-337-1118)
GS-US-337-1118: An Open-Label, Multicenter Study To Evaluate The Efficacy And Safety Of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin For 12 or 24 Weeks In Chronic Genotype 1 HCV Infected Subjects Who Participated In A Prior Gilead-Sponsored HC
- Flamm, Steven L (PD/PI)
Project: Research project